Diagnosis and management of urinary bladder paragangliomas: A Sino‐American‐European retrospective observational study
Yingxian Pang,Jing Zhang,Jingjing Jiang,Christina Pamporaki,Minghao Li,Nicole Bechmann,Leah Meuter,Yongbao Wei,Haijian Huang,Shenghui Huang,Xunbin Yu,Mercedes Robledo,Miguel J. Soria,Dewen Zhong,Shangyuan Xu,Henri J. L. M. Timmers,Johan F. Langenhuijsen,Xiaofeng Chen,Wanglong Deng,Timo Deutschbein,Hanna Remde,Long Wang,Hanyu Yao,Bin Yan,Annika M. A. Berends,Michiel N. Kerstens,Yazhuo Jiang,Joakim Crona,Ning Xu,Hai Cai,Yanlin Wen,Anguo Wang,Ji Wu,Zongpin Zhang,Jinzhuo Ning,Fan Cheng,Xiang Chen,Jing Wang,Bin Xie,Danlei Chen,Yujun Liu,Longfei Liu,Karel Pacak,Graeme Eisenhofer,Jacques W. M. Lenders
DOI: https://doi.org/10.1111/cen.15058
2024-04-14
Clinical Endocrinology
Abstract:Objective Paragangliomas of the urinary bladder (UBPGLs) are rare neuroendocrine tumours and pose a diagnostic and surgical challenge. It remains unclear what factors contribute to a timely presurgical diagnosis. The purpose of this study is to identify factors contributing to missing the diagnosis of UBPGLs before surgery. Design, Patients and Measurements A total of 73 patients from 11 centres in China, and 51 patients from 6 centres in Europe and 1 center in the United States were included. Clinical, surgical and genetic data were collected and compared in patients diagnosed before versus after surgery. Logistic regression analysis was used to identify clinical factors associated with initiation of presurgical biochemical testing. Results Among all patients, only 47.6% were diagnosed before surgery. These patients were younger (34.0 vs. 54.0 years, p
endocrinology & metabolism